Skip to main content

Health condition

Uterine sarcoma vs fibroid

Uterine sarcomas are rare cancers that can masquerade as common fibroids; growth after menopause, rapid enlargement and certain MRI features raise suspicion, and they change the safest surgical approach.

Why trust this guide

  • 01

    Editorial team

    Written by our editorial team from the UK sources listed on each page.

  • 02

    Sourced from guidance

    Checked against current NHS and UK specialist society guidance at the time of review.

  • 03

    Current for 2026

    Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.

Key facts

The essentials at a glance.

The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.

  • Fibroids are extremely common; uterine sarcomas are rare - but the two can look alike

  • A "fibroid" enlarging after menopause is a red flag until proven otherwise

  • Suspicion changes surgery: intact removal, avoiding morcellation, protects outcomes

  • MRI with specialist review is the best imaging discriminator available

Understanding the condition

What it is and what happens next.

What causes it, how it is diagnosed, and the treatment routes available in the UK.

What it is and how it feels

The overwhelming majority of uterine masses are benign fibroids, and no test short of pathology is perfect at separating the rare sarcoma hiding among them. Concern rises with age, growth after the menopause (when fibroids should shrink), unusually rapid enlargement, pain, abnormal bleeding, and MRI characteristics such as irregular margins and particular signal patterns - findings that warrant review by a gynae-oncology MDT before any surgery.

Diagnosis and treatment routes

The practical consequence concerns technique: power morcellation, which fragments tissue to remove it through keyhole incisions, can disseminate an unsuspected sarcoma and worsen its outcome, so suspicious masses are removed intact. Where sarcoma is confirmed - leiomyosarcoma, endometrial stromal sarcoma or others - staging and further treatment follow sarcoma principles. Women weighing fibroid surgery options are entitled to a clear discussion of this small but consequential risk. If you are waiting for results or want a second opinion on a proposed plan, a private consultation with a specialist who treats this condition regularly can usually be arranged quickly, and most will review your existing scans, biopsy reports and MDT correspondence.

Seeing a specialist

Who to see, and how quickly you can be seen.

The specialist for this condition is usually a consultant gynaecological oncologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.

A quiet reminder

This guide is for information, not medical advice.

Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.

Frequently asked

Common questions about Uterine sarcoma vs fibroid.

Quick, plain-English answers to what people ask us most.

  • What is the difference between uterine sarcoma and a fibroid?

    Fibroids are benign (non-cancerous) growths of the womb muscle, very common and generally not dangerous, while uterine sarcoma is a rare cancerous tumour arising from the same muscle tissue; the two can look similar on initial imaging, which is the main clinical challenge.

  • What causes uterine sarcoma?

    The exact cause is usually unknown; it isn't thought to arise from a benign fibroid turning cancerous (this is extremely rare), but rather develops independently, with previous pelvic radiotherapy being one recognised risk factor.

  • What symptoms might suggest sarcoma rather than a fibroid?

    Rapid growth of a suspected fibroid, especially after menopause, unusual bleeding, or fibroid-like symptoms that don't fit the typical pattern can raise suspicion, though there's often no way to be certain without further specific imaging or, ultimately, tissue examination.

  • Is uterine sarcoma dangerous?

    Yes, it is a cancer that can be aggressive and requires prompt specialist treatment, unlike a fibroid, which is why distinguishing between the two, where there's uncertainty, matters.

  • How are fibroids and uterine sarcoma distinguished?

    Specific MRI features can raise or lower suspicion of sarcoma, and sometimes blood tests (like LDH levels) are used alongside imaging; ultimately, a definitive answer often requires examining the tissue after removal, since a needle biopsy isn't always reliable for this distinction.

  • Can uterine sarcoma be treated?

    Yes, treatment usually involves surgery to remove the tumour and the womb, sometimes combined with chemotherapy or radiotherapy depending on the stage and specific type of sarcoma.

  • How common is uterine sarcoma compared with fibroids?

    Uterine sarcoma is rare, while fibroids are extremely common, affecting a large proportion of women at some point; this reassuring rarity is why most rapidly growing masses ultimately turn out to be fibroids rather than sarcoma.

  • Does morcellation (fibroid surgery technique) matter in this context?

    Yes, because morcellation (cutting a fibroid into smaller pieces during minimally invasive surgery) can potentially spread undetected cancer cells if a mass turns out to be a sarcoma, so specialists carefully weigh imaging findings and risk factors before choosing a surgical technique.

  • When should I see a gynaecologist about a rapidly growing fibroid, and how quickly can I be seen privately?

    See a gynaecologist promptly if a suspected fibroid grows rapidly, especially after menopause. NHS urgent referral pathways aim for rapid assessment; private gynaecologists can often see you within about one to two weeks.